Class information for:
Level 1: STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
233 3776 34.9 77%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
408 16067 STATINS//EZETIMIBE//SIMVASTATIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 STATINS Author keyword 61 11% 14% 542
2 LOW DENSITY LIPOPROTEIN CHOLESTEROL Author keyword 23 17% 3% 122
3 ATORVASTATIN Author keyword 21 11% 5% 182
4 ROSUVASTATIN Author keyword 18 16% 3% 103
5 LIPID LOWERING THERAPY Author keyword 15 27% 1% 47
6 LIPID LOWERING Author keyword 13 25% 1% 45
7 LIPID LOWERING DRUGS Author keyword 12 26% 1% 42
8 LDL C Author keyword 12 21% 1% 51
9 SECT ATHEROSCLEROSIS LIPID Address 9 83% 0% 5
10 ANTILIPEMIC AGENTS Author keyword 8 32% 1% 21

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 STATINS 61 11% 14% 542 Search STATINS Search STATINS
2 LOW DENSITY LIPOPROTEIN CHOLESTEROL 23 17% 3% 122 Search LOW+DENSITY+LIPOPROTEIN+CHOLESTEROL Search LOW+DENSITY+LIPOPROTEIN+CHOLESTEROL
3 ATORVASTATIN 21 11% 5% 182 Search ATORVASTATIN Search ATORVASTATIN
4 ROSUVASTATIN 18 16% 3% 103 Search ROSUVASTATIN Search ROSUVASTATIN
5 LIPID LOWERING THERAPY 15 27% 1% 47 Search LIPID+LOWERING+THERAPY Search LIPID+LOWERING+THERAPY
6 LIPID LOWERING 13 25% 1% 45 Search LIPID+LOWERING Search LIPID+LOWERING
7 LIPID LOWERING DRUGS 12 26% 1% 42 Search LIPID+LOWERING+DRUGS Search LIPID+LOWERING+DRUGS
8 LDL C 12 21% 1% 51 Search LDL+C Search LDL+C
9 ANTILIPEMIC AGENTS 8 32% 1% 21 Search ANTILIPEMIC+AGENTS Search ANTILIPEMIC+AGENTS
10 EUROASPIRE 7 46% 0% 12 Search EUROASPIRE Search EUROASPIRE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PRAVASTATIN 235 24% 23% 869
2 SCANDINAVIAN SIMVASTATIN SURVIVAL 138 41% 7% 265
3 AVERAGE CHOLESTEROL LEVELS 135 30% 10% 371
4 LIPID LOWERING THERAPY 76 26% 7% 259
5 SECONDARY PREVENTION 53 11% 12% 444
6 SIMVASTATIN 51 11% 11% 432
7 PRIMARY PREVENTION 50 12% 10% 396
8 ATORVASTATIN 46 12% 10% 368
9 TREATMENT PANEL III 45 17% 7% 246
10 LOWERING THERAPY 41 29% 3% 119

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Statins and All-Cause Mortality in High-Risk Primary Prevention A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants 2010 188 31 74%
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention 2009 168 53 66%
Effect of statins on risk of coronary disease - A meta-analysis of randomized controlled trials 1999 758 41 68%
Statins for the primary prevention of cardiovascular disease 2013 44 190 39%
Primary prevention of cardiovascular diseases with statin therapy - A meta-analysis of randomized controlled trials 2006 181 26 73%
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials 2011 100 105 52%
A systematic review and meta-analysis on the therapeutic equivalence of statins 2010 86 73 71%
The Relationship Between Reduction in Low-Density Lipoprotein Cholesterol by Statins and Reduction in Risk of Cardiovascular Outcomes: An Updated Meta-Analysis 2009 69 28 75%
Statin Therapy in the Prevention of Recurrent Cardiovascular Events A Sex-Based Meta-analysis 2012 47 52 62%
Cholesterol lowering with statin drugs, risk of stroke, and total mortality - An overview of randomized trials 1997 538 39 59%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SECT ATHEROSCLEROSIS LIPID 9 83% 0.1% 5
2 ANAL COST EFFECT CARE 8 39% 0.4% 15
3 CHOLESTEROL EDUC PROGRAM 6 100% 0.1% 4
4 HEART PROTECT STUDY 5 63% 0.1% 5
5 US MED SCI AFFAIRS 5 50% 0.2% 7
6 CLIN EPIDEMIOL POPULAT STUDIES 5 55% 0.2% 6
7 CARDIAC REHABIL CHOLESTEROL CLIN 4 75% 0.1% 3
8 INDEPENDENT LIPIDOL 3 100% 0.1% 3
9 EPIDEMIOL PREVENT PHARMACOL 3 60% 0.1% 3
10 HEART DIS PREVENT CLIN 3 32% 0.2% 7

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000175118 NK 104//PITAVASTATIN//CAS 147526 32 7
2 0.0000174480 EZETIMIBE//CHOLESTEROL ABSORPTION INHIBITOR//COLESEVELAM
3 0.0000157968 POLYPILL//CORONARY HEART DISEASE RISK FUNCTIONS//REGICOR
4 0.0000157119 STATIN MYOPATHY//STATIN INTOLERANCE//MYALGIA
5 0.0000136281 LAROPIPRANT//NIACIN//HM74A
6 0.0000128731 FLUVASTATIN//PLEIOTROPIC EFFECTS//HMG COA REDUCTASE INHIBITOR
7 0.0000108060 ABNORMAL BLOOD LIPIDS//BEYIN CERRAHI SERV//BRAIN INJURY GRP BIOMED
8 0.0000094145 FENOFIBRIC ACID//FENOFIBRATE//FIBRATES
9 0.0000093773 PRAVASTATIN//HMG COA REDUCTASE INHIBITOR//COMPACTIN
10 0.0000091106 ASSOC CARDIAC//ASSOC RIC CARDIOL//CLIN EXPT MED 2